SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019049
Filing Date
2022-09-29
Accepted
2022-09-29 16:15:25
Documents
12
Period of Report
2022-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K flgt-20220924.htm   iXBRL 8-K 49647
  Complete submission text file 0000950170-22-019049.txt   162893

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgt-20220924.xsd EX-101.SCH 2482
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgt-20220924_pre.xml EX-101.PRE 10506
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgt-20220924_lab.xml EX-101.LAB 12798
6 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20220924_htm.xml XML 4530
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 221280735
SIC: 8071 Services-Medical Laboratories